scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1001668316 |
P356 | DOI | 10.1186/1476-4598-10-124 |
P953 | full work available online at | https://europepmc.org/articles/PMC3193026 |
https://europepmc.org/articles/PMC3193026?pdf=render | ||
https://link.springer.com/content/pdf/10.1186/1476-4598-10-124.pdf | ||
https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/1476-4598-10-124 | ||
P932 | PMC publication ID | 3193026 |
P698 | PubMed publication ID | 21962230 |
P5875 | ResearchGate publication ID | 51684315 |
P50 | author | Hailin Tang | Q91883057 |
P2093 | author name string | Rong Wang | |
Wei Liu | |||
Lan Xiao | |||
Xiaoping Liu | |||
Xiaoling Li | |||
Zuping Zhang | |||
Guiyuan Li | |||
Minghua Wu | |||
Baoxin Zhang | |||
Hongmei Lu | |||
Zeyou Wang | |||
P2860 | cites work | International Journal of Oncology | Q6051527 |
PLOS One | Q564954 | ||
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 | ||
The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas | Q24293141 | ||
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry | Q24536837 | ||
Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas | Q24550860 | ||
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B | Q24564757 | ||
Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis | Q24656948 | ||
The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
Prediction of mammalian microRNA targets | Q27860498 | ||
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells | Q28245307 | ||
Extensive modulation of a set of microRNAs in primary glioblastoma | Q28263314 | ||
The epigenomics of cancer | Q28289975 | ||
Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells | Q81366664 | ||
Cancer epigenetics | Q81611376 | ||
Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma | Q84030785 | ||
??? | Q24685269 | ||
The role of DNA methylation in mammalian epigenetics | Q29617979 | ||
GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia | Q33295394 | ||
Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation | Q33365279 | ||
Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas | Q33381892 | ||
Discovery of DNA methylation markers in cervical cancer using relaxation ranking | Q33386224 | ||
MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. | Q33494538 | ||
CpG island hypermethylation in human astrocytomas | Q33766932 | ||
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. | Q33888431 | ||
An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer | Q34090543 | ||
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer | Q34188991 | ||
A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases | Q34343364 | ||
Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases | Q34587622 | ||
Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome. | Q34746842 | ||
DNA methylation in cancer: too much, but also too little | Q34770545 | ||
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. | Q34783833 | ||
Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis | Q34888915 | ||
Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma | Q35103214 | ||
A microRNA DNA methylation signature for human cancer metastasis | Q36861111 | ||
DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer. | Q37350311 | ||
ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis | Q38289425 | ||
Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia | Q38303652 | ||
DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis | Q39847607 | ||
Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. | Q39975102 | ||
Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma | Q40086269 | ||
Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment. | Q40102545 | ||
Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. | Q40248583 | ||
TP53 promoter methylation in human gliomas | Q40396455 | ||
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide | Q40522471 | ||
Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. | Q40595717 | ||
Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors | Q40621367 | ||
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma | Q42013793 | ||
DNA methylation mediated by a microRNA pathway | Q43104318 | ||
Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene | Q43750899 | ||
DNA repair gene O6-methylguanine-DNA methyltransferase: promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors | Q44263002 | ||
Promoter hypermethylation of mismatch repair gene hMLH1 predicts the clinical response of malignant astrocytomas to nitrosourea | Q45299151 | ||
Promoter Hypermethylation of the DNA Repair Gene O6‐Methylguanine‐DNA Methyltransferase is an Independent Predictor of Shortened Progression Free Survival in Patients with Low‐grade Diffuse Astrocytomas | Q48311590 | ||
Promoter hypermethylation identifies progression risk in bladder cancer. | Q51033077 | ||
Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy | Q51831412 | ||
A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. | Q53342370 | ||
Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas | Q53595703 | ||
Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma | Q72970952 | ||
Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss | Q80778544 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | DNA methylation | Q874745 |
neoplastic gene expression regulation | Q66660300 | ||
P304 | page(s) | 124 | |
P577 | publication date | 2011-01-01 | |
2011-09-30 | |||
P1433 | published in | Molecular Cancer | Q15724585 |
P1476 | title | MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma | |
MiR-185 Targets the DNA Methyltransferases 1 and Regulates Global DNA Methylation in human glioma | |||
P478 | volume | 10 |
Q24633772 | A Systematic Review of MicroRNA in Glioblastoma Multiforme: Micro-modulators in the Mesenchymal Mode of Migration and Invasion |
Q42515905 | A composite network of conserved and tissue specific gene interactions reveals possible genetic interactions in glioma. |
Q38356196 | A major role for microRNAs in glioblastoma cancer stem-like cells |
Q26830652 | An insight into the various regulatory mechanisms modulating human DNA methyltransferase 1 stability and function |
Q36985123 | CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma |
Q55128349 | Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors. |
Q38668171 | Circulating epigenetic biomarkers in melanoma. |
Q42578720 | Cis-acting elements in its 3' UTR mediate post-transcriptional regulation of KRAS. |
Q26998741 | DNA methylation and microRNA dysregulation in cancer |
Q36497752 | DNA methylation is critical for tooth agenesis: implications for sporadic non-syndromic anodontia and hypodontia. |
Q33989539 | Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome |
Q54322646 | Elevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in clear cell renal cell carcinoma |
Q34392645 | Epigenetic alteration and microRNA dysregulation in cancer |
Q38319591 | Epigenetic alterations in cancer and personalized cancer treatment |
Q48227731 | Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members |
Q51770872 | Epigenetics and MicroRNAs in Cancer |
Q36908574 | Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer |
Q42250991 | Genome-wide screening identifies Plasmodium chabaudi-induced modifications of DNA methylation status of Tlr1 and Tlr6 gene promoters in liver, but not spleen, of female C57BL/6 mice |
Q36757053 | HBP1-Mediated Transcriptional Regulation of DNA Methyltransferase 1 and Its Impact on Cell Senescence |
Q38989340 | Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP. |
Q90788856 | Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1α stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment |
Q38430627 | Identification of Driver Genes and Key Pathways of Pediatric Brain Tumors and Comparison of Molecular Pathogenesis Based on Pathologic Types |
Q91651312 | Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles |
Q39051113 | Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake |
Q34401887 | Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines |
Q49874623 | Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma. |
Q55057712 | LRRC4 haplotypes are associated with pituitary adenoma in a Chinese population. |
Q42314347 | MeDeCom: discovery and quantification of latent components of heterogeneous methylomes. |
Q51813662 | Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage |
Q35781470 | MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells |
Q39210882 | MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine |
Q38935102 | MiR-185 is involved in human breast carcinogenesis by targeting Vegfa |
Q47824018 | MicroRNA-139-5p/Flt1/Wnt/β-catenin regulatory crosstalk modulates the progression of glioma. |
Q38774242 | MicroRNA-92a Promotes Colorectal Cancer Cell Growth and Migration by Inhibiting KLF4. |
Q36826818 | MicroRNAs 185, 96, and 223 Repress Selective High-Density Lipoprotein Cholesterol Uptake through Posttranscriptional Inhibition |
Q36588163 | Oestrogen receptor β regulates epigenetic patterns at specific genomic loci through interaction with thymine DNA glycosylase. |
Q53556224 | Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. |
Q97644181 | Protocadherins at the Crossroad of Signaling Pathways |
Q38885469 | Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer |
Q64069671 | Relationship between single nucleotide polymorphisms in the 3'UTR of amyloid precursor protein and risk of Alzheimer's disease and its mechanism |
Q36985088 | Repression of ATR pathway by miR-185 enhances radiation-induced apoptosis and proliferation inhibition |
Q33781657 | SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B. |
Q49788159 | The Homeotic Protein SIX3 Suppresses Carcinogenesis and Metastasis through Recruiting the LSD1/NuRD(MTA3) Complex |
Q38109412 | The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus |
Q51768235 | Ultraviolet A irradiation induces senescence in human dermal fibroblasts by down-regulating DNMT1 via ZEB1. |
Q51275718 | Upregulated miR-9-3p Promotes Cell Growth and Inhibits Apoptosis in Medullary Thyroid Carcinoma by Targeting BLCAP. |
Q47134084 | let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery |
Q36782656 | miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells |
Q52945589 | miR-107 Promotes Proliferation and Inhibits Apoptosis of Colon Cancer Cells by Targeting Prostate Apoptosis Response-4 (Par4). |
Q36545987 | miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1. |
Q51037810 | miR-126-5p Restoration Promotes Cell Apoptosis in Cervical Cancer by Targeting Bcl2l2. |
Q39041981 | miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer |
Q38712973 | miR-202 Promotes Cell Apoptosis in Esophageal Squamous Cell Carcinoma by Targeting HSF2. |
Q38849525 | miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL. |
Q38780114 | miRNA-497 Negatively Regulates the Growth and Motility of Chondrosarcoma Cells by Targeting Cdc25A. |
Q34286618 | miRNAs and cancer: An epigenetics view |
Search more.